Shenzhen - Delayed Quote CNY

Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ)

19.74 +0.03 (+0.15%)
At close: April 26 at 3:04 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Hong Xian Ruan President & Executive Chairman -- -- 1966
Mr. Sishun Dai Chief Financial Officer -- -- 1980
Mr. Yong Zhang Executive Director -- -- 1978
Mr. Guowei Ruan Executive Director -- -- 1977
Mr. Zheng Hong Li VP & Secretary -- -- 1986
Donglei Xiao Accounting Supervisor -- -- --

Yixintang Pharmaceutical Group Co., Ltd.

No.1, Hongxiang Road
Economic Development Zone
Kunming
China
86 40 0988 9889 https://www.hx8886.com
Sector: 
Healthcare

Description

Yixintang Pharmaceutical Group Co., Ltd., together with its subsidiary, operates a chain of drugstores in China. It also produces and sells medicinal materials, Chinese herbal medicines, and food and health products, as well as engages in the drug distribution activities. It operates stores in Yunnan, Guizhou, Guangxi, Sichuan, Shanxi, Chongqing, Tianjin, Shanghai, Qiong, and other provinces and municipalities. It also sells products online. The company was formerly known as Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. and changed its name to Yixintang Pharmaceutical Group Co., Ltd. in June 2019. Yixintang Pharmaceutical Group Co., Ltd. was founded in 2000 and is headquartered in Kunming, China.

Corporate Governance

Yixintang Pharmaceutical Group Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • May 26, 2023
    Ex-Dividend Date

Upcoming Events